pharmaceutical stocks
Media
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Mental Health Portfolio
In a significant move that reshapes the landscape of mental health therapeutics, Johnson & Johnson (NYSE: JNJ) announced today its acquisition of Intra-Cellular...
Media
Moderna Stock Plunges as Company Slashes 2025 Revenue Forecast and Announces Major Cost Cuts
Moderna (NASDAQ: MRNA) shares tumbled 18% in premarket trading on Monday after the biotechnology company significantly lowered its 2025 revenue forecast and announced...
